businesspress24.com - Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compli
 

Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compliance Investment, an Industrial Info News Alert

ID: 1069714

(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 01/04/12 -- Researched by Industrial Info Resources (Sugar Land, Texas) -- In 2009, (NASDAQ:TEVA) (Petah Tikva, Israel), the largest U.S. manufacturer of , was ordered by the U.S. Food and Drug Administration (FDA) to cease operations at its facility in St. Joseph, Missouri. The subsidiary of Israel-based Teva Pharmaceuticals had failed to comply with current Good Manufacturing Practice (cGMP) regulations in its quality control, employee training and manufacturing practices. However, the compliance project is slowly winding down, and the plant should resume operations in the first quarter of this year.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principleâ„¢, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.





Contact:
Joe Govreau
713-783-5147




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Infocast's Projects & Money Returns -- Jan 2012
Interference Filters for Photolithography
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 04.01.2012 - 05:40 Uhr
Sprache: Deutsch
News-ID 1069714
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SUGAR LAND, TX


Phone:

Kategorie:

Consulting


Anmerkungen:


Diese Pressemitteilung wurde bisher 195 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compliance Investment, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von

Industrial Info Resources (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Industrial Info Resources



 

Who is online

All members: 10 676
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 444


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.